Fundraising Fox

BioSig Technologies

NASDAQ: STEX

Los Angeles, US · Delaware corporation

Healthtech

Founders & leadership

KL
Kenneth L. LondonerChairman and Chief Executive Officer
FG
Ferdinand GroenewaldChief Financial Officer
AA
Anthony AmatoChief Executive Officer
MG
Michael Graydon Fleming, Jr.Chief Commercial Officer
JS
John SieckhausChief Operating Officer
SJ
Steven J BuhalyChief Financial Officer
SE
Steven E. AbelmanDirector
FD
Frederick D. HrkacDirector
CB
Chris BaerDirector
DF
Donald F. BrowneDirector
JJ
James J. BarryDirector
DW
David Weild IVDirector

Reported raises · per SEC filings

Form D private placements
▶$819KraisedMar 2025 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven E. AbelmanDirector
  • Ferdinand GroenewaldExecutive Officer
  • Frederick D. HrkacDirector
  • Anthony AmatoExecutive Officer, Director
  • Chris BaerDirector
  • Donald F. BrowneDirector
Offering amount
$819K
Amount sold
$819K
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJun 2024 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony AmatoExecutive Officer, Director
  • Frederick D. HrkacExecutive Officer, Director
  • Donald F. BrowneDirector
  • Steven E. AbelmanDirector
  • Chris BaerDirector
Offering amount
$3M
Amount sold
$3M
Sales commissions
$240K
Placement agents
H.C. Wainwright & Co.
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJun 2024 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven E. AbelmanDirector
  • Frederick D. HrkacExecutive Officer
  • Chris BaerDirector
  • Donald F. BrowneDirector
  • Anthony AmatoExecutive Officer, Director
Offering amount
$1.1M
Amount sold
$1.1M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJan 2024 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John SieckhausExecutive Officer
  • James J. BarryDirector
  • Frederick D. HrkacDirector
  • David Weild IVDirector
  • Donald E. FoleyDirector
  • James L. KleinDirector
  • Patrick J. GallagherDirector
  • Kenneth L. LondonerExecutive Officer, Director
  • Michael Graydon Fleming, Jr.Executive Officer
  • Steven J BuhalyExecutive Officer
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$860.9KraisedOct 2023 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David Weild IVDirector
  • Frederick D. HrkacDirector
  • Kenneth L. LondonerExecutive Officer, Director
  • Patrick J. GallagherDirector
  • Michael Graydon Fleming, Jr.Executive Officer
  • John SieckhausExecutive Officer
  • Donald E. FoleyDirector
  • Steven J BuhalyExecutive Officer
  • James J. BarryDirector
  • James L. KleinDirector
Offering amount
$860.9K
Amount sold
$860.9K
Sales commissions
$59.8K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedOct 2023 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven J BuhalyExecutive Officer
  • Frederick D. HrkacDirector
  • Michael Graydon Fleming, Jr.Executive Officer
  • James J. BarryDirector
  • Kenneth L. LondonerExecutive Officer, Director
  • Patrick J. GallagherDirector
  • Donald E. FoleyDirector
  • John SieckhausExecutive Officer
  • James L. KleinDirector
  • David Weild IVDirector
Offering amount
$1.2M
Amount sold
$1.2M
Sales commissions
$30K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$794KraisedSep 2023 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John SieckhausExecutive Officer
  • Steven J BuhalyExecutive Officer
  • James J. BarryDirector
  • Kenneth L. LondonerExecutive Officer, Director
  • Frederick D. HrkacDirector
  • James L. KleinDirector
  • Donald E. FoleyDirector
  • Patrick J. GallagherDirector
  • David Weild IVDirector
  • Michael Graydon Fleming, Jr.Executive Officer
Offering amount
$794K
Amount sold
$794K
Sales commissions
$53K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedAug 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald E. FoleyDirector
  • Kenneth L. LondonerExecutive Officer, Director
  • John SieckhausExecutive Officer
  • Steven J BuhalyExecutive Officer
  • James J. BarryDirector
  • Patrick J. GallagherDirector
  • Michael Graydon Fleming, Jr.Executive Officer
  • James L. KleinDirector
  • David Weild IVDirector
  • Frederick D. HrkacDirector
Offering amount
$2.2M
Amount sold
$2.2M
Sales commissions
$150K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.